gamma-aminobutyric acid has been researched along with Fatigue Syndrome, Chronic in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gamma-aminobutyric acid is a major inhibitory neurotransmitter in the central nervous system." | 2.44 | [Gamma-aminobutyric acid--metabolism and its disorders]. ( Kowalski, A; Rebas, E; Zylińska, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalski, A | 1 |
| Rebas, E | 1 |
| Zylińska, L | 1 |
| Moore, AR | 1 |
| Straube, S | 1 |
| Paine, J | 1 |
| Phillips, CJ | 1 |
| Derry, S | 1 |
| McQuay, HJ | 1 |
| Murrough, JW | 1 |
| Mao, X | 1 |
| Collins, KA | 1 |
| Kelly, C | 1 |
| Andrade, G | 1 |
| Nestadt, P | 1 |
| Levine, SM | 1 |
| Mathew, SJ | 1 |
| Shungu, DC | 1 |
| Hannestad, U | 1 |
| Theodorsson, E | 1 |
| Evengård, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gamma-aminobutyric acid and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
[Gamma-aminobutyric acid--metabolism and its disorders].
Topics: Anxiety Disorders; Central Nervous System Diseases; Fatigue Syndrome, Chronic; gamma-Aminobutyric Ac | 2007 |
1 trial available for gamma-aminobutyric acid and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain.
Topics: Activities of Daily Living; Adult; Analgesics; Fatigue Syndrome, Chronic; Female; Fibromyalgia; gamm | 2010 |
2 other studies available for gamma-aminobutyric acid and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.
Topics: Adult; Cerebral Ventricles; Depressive Disorder, Major; Fatigue Syndrome, Chronic; Female; gamma-Ami | 2010 |
beta-Alanine and gamma-aminobutyric acid in chronic fatigue syndrome.
Topics: Adult; beta-Alanine; Fatigue Syndrome, Chronic; Female; gamma-Aminobutyric Acid; Humans; Male; Middl | 2007 |